• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 53
  • 16
  • 13
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • Tagged with
  • 115
  • 115
  • 20
  • 20
  • 19
  • 17
  • 16
  • 14
  • 13
  • 11
  • 9
  • 8
  • 8
  • 8
  • 7
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
81

The von Hippel-Lindau protein and collagen IV alpha 2 : an insight into the mechanisms by which the von Hippel-Lindau protein regulates extracellular matrix assembly and function

Ramlal, Nishant. January 2008 (has links)
The von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome that is transmitted in an autosomal dominant manner. The disease is characterized by the formation of highly angiogenic tumors in many organs but the main causes of mortality are renal cell carcinomas and hemangioblastomas. Mutations in the VHL protein are responsible for the pathogenesis of the disease. VHL associates with elongin Band C to form the VBC complex. The cullin 2 protein (CUL2) and ring box protein 1 (RBX1) also associate with the VBC complex to form an E3 ubiquitin ligase involved in the ubiquitination and subsequent degradation of the hypoxia inducible transcription factor (HIF2alpha). Mutations in VHL that abrogate its E3 ligase activity lead to increased levels ofHIF2alpha and the subsequent accumulation of pro-proliferative and pro-angiogenic HIF2alpha target genes. VHL also has an important function in the regulation of extracellular matrix (ECM) assembly which is independent of its HIF2alpha regulation pathway. VHL's regulation of ECM assembly was shown to have important consequences for tumor angiogenesis and cell invasion. It was shown to be necessary for the proper assembly of a fibronectin matrix and was most recently found to interact with collagen IV alpha 2 (COL4A2). The aim of this thesis is to further characterize the VHL-COL4A2 interaction. VHL was shown to interact directly and specifically to COL4A2 and is necessary for proper COL4A2 matrix assembly. The association of VHL with COL4A2 appears to be independent of its functions as an E3 ubiquitn ligase and CUL2 was identified as part of the VBC complex that associates with collagen IV (COL4). Furthermore, a strategy to identify the binding site of VHL on COL4A2 has been employed and is in progress. These experiments represent the beginning of investigations into the novel interaction between VHL and COL4A2.
82

Investigação em estimulação tátil por jatos de CO2 aplicada à comunicação alternativa

Cunha, José Carlos da 03 August 2012 (has links)
A estimulação vibrotátil tem sido utilizada para promover a comunicação alternativa em pessoas com deficiência visual e/ou auditiva. Por meio dela, ativam-se os receptores da pele que promovem a transdução do estímulo mecânico em uma resposta eletrofisiológica enviada ao SNC. O objetivo do presente trabalho é o de investigar a resposta à estimulação tátil por jato de CO2 como método de comunicação alternativa. Materiais e Métodos: desenvolveu-se um sistema de estimulação tátil por jato de CO2, no qual pressão e fluxo do gás são controlados e o gás é aplicado à pele por meio de uma agulha, cuja velocidade de deslocamento pode ser ajustada entre 20 e 100 mm/s. O instrumento atua como um plotter tátil. Foram realizados testes com 25 voluntários sem deficiências físicas e/ou cognitivas, nos quais avaliaram-se as respostas psicofísica e cognitiva e a taxa de reconhecimento correto de dezenove letras aplicadas na região abdominal, com intensidade estimulatória equivalente a três vezes o limiar de percepção. Resultados: o limiar de percepção da força encontrado foi de 60 mgf e a estimulação fluxotátil foi realizada utilizando-se a força de 180 mgf. Em testes cegos, a melhor taxa de reconhecimento correto das letras atingiu a média de 68 (±17) %, e ocorreu na velocidade de 40 mm/s e frequência de 1,33 Hz. As letras D, O, M e N apresentaram as menores taxas médias de reconhecimento, com 29%, 37%, 47% e 51%, respectivamente, devido à morfologia das mesmas gerar dúvida na diferenciação entre elas, enquanto as melhores taxas foram observadas sobre as letras I, U, J e B com 87%, 71%, 68% e 65%, respectivamente. Conclusões: o sistema desenvolvido possibilitou a execução dos testes e a coleta das informações, necessárias à realização da pesquisa. Os resultados mostraram que a resposta psicofísica à estimulação fluxotátil está relacionada à faixa de frequência de resposta dos discos de Merkel, com resposta máxima em 1,33 Hz, correspondente a velocidade de deslocamento da agulha de estimulação em 40 mm/s. A morfologia das letras e a velocidade de deslocamento da agulha de estimulação influenciaram nas taxas de reconhecimento das letras. / Vibrotactile stimulation has been used to promote alternative communication for people with visual and hearing impairments. The stimuli activate the receptors of the skin that promote the transduction of mechanical stimuli into an electrophysiological response sent to the CNS. Objective: to investigate the response to tactile stimulation by a CO2 jet as a method of alternative. Materials and Methods: a cutaneous stimulation system was developed which yields jets of CO2 on the subject’s skin at stimulating speeds varying from 20 up to 100 mm/s, by means of an injection needle. The instrument acts as a tactile plotter. Tests were conducted in twenty five volunteers without physical and/or cognitive disabilities in whose the psychophysical and cognitive responses were evaluated as well as the rate of correct recognition of nineteen characters applied to the abdominal region, with the stimulus intensity equivalent to three times the threshold of perception. Results: a force perception threshold of 60 mgf was found and the fluxtactile stimulation was performed using a force of 180 mgf. In blind tests, the best rate of correct character recognition had an average of 68 (± 17)%, and occurred at the speed of 40 mm/s and frequency of 1.33 Hz. The characters D, O, M and N have shown the lower average rate of recognition with 29%, 37%, 47% and 51%, respectively, due to the uncertainty generated by their similar morphology, whereas the best rates were observed for letters I, U, J, and B with 87%, 71%, 68% and 65%, respectively. Conclusions: the developed system enabled the experimental research and the acquisition of information necessary for carrying out the research. The results have shown that the psychophysical responses to fluxtactile stimuli are related to the frequency response of the Merkel discs, with maximal performance at 1.33 Hz, corresponding to the speed of the stimulation needle of 40 mm/s. The morphology of the graphical characters and the stimulation needle speed influenced the rates of letters recognition.
83

Estudo estrutural e termodinâmico de mutantes da proteína c-ABL resistentes ao IMATINIB / Strucutural an thermodynamic study from c-ABL mutant proteins resistant to IMATINIB

Elen Gomes Pereira 00 June 2009 (has links)
As leucemias são desordens proliferativa nas células tronco hematopoiéticas pluripotentes caracterizada por mutações que comprometem seus precursores mielóides ou linfóides levando ao desenvolvimento de leucemias similares quanto ao fenótipo (Mielóide ou Linfóide) e forma (Crônica ou Aguda). Descrito em 1960, o cromossomo philadelphia (Ph) foi a primeira anomalia cromossômica associada a uma neoplasia, a Leucemia Mielóide Crônica (LMC). Em 1973, foi demonstrado que o cromossomo Ph resulta da translocação recíproca entre os braços longos do cromossomo 9 e 22 [t(9;22)(q34;q11)], produzindo um gene quimérico BCR-ABL, encontrado em 95% dos casos de LMC. A proteína quimérica codificada, BCR-ABL, com atividade tirosina quinase descontrolada, é o fator causal da LMC. Durante os anos 1990, uma série de moléculas sintéticas foram desenvolvidas e testadas para inibir especificamente a atividade tirosina quinase da proteína BCR-ABL, o Imatinib (STI-571 ou Gleevec) foi a primeira dessas drogas aprovadas e usadas como agente terapêutico contra a LMC, demonstrando redução do número de células leucêmicas em quase todos pacientes. No entanto muitos pacientes com resistências primárias ou secundárias foram frequentemente relatados. Os mecanismos de resistência são provavelmente heterogêneos, e no mínimo dois mecanismos envolvendo o gene BCR-ABL foram descritos em estudos realizados in vivo: amplificação do gene e ocorrência de mutações que resultam em substituições de aminoácidos associadas com o fenótipo de resistência. Diferentes níveis de resistência são frequentemente associadas a mutações pontuais recorrentes encontradas no domínio quinase da proteína c-ABL em regiões como: sítio catalítico, alça de ativação (A-loop) e alça de fosforilação (P-loop). Os primeiros estudos computacionais foram realizados com o mutante Thr334Ile e mutações na região do P-loop, e ajudaram a entender num nível molecular, os mecanismos de resistência ao Imatinib. Neste trabalho, realizamos um estudo estrutural e termodinâmico das interações entre os ligantes Imatinib e Nilotinib no sítio ativo da proteína c-ABL selvagem e em 12 proteínas com mutações específicas, além de determinar a importância do solvente (com particular interesse na molécula de água denominada Cw - que medeia a interação fármaco-proteína) no processo de resistência aos fármacos. No presente trabalho, utilizamos o método semi-empírico de energia de interação linear (LIE) de maneira alternativa: analisando as interações entre diferentes mutantes da proteína c-ABL e um inibidor (Imatinib ou Nilotinib). Os coeficientes de LIE obtidos foram os seguintes: com Cw fixa (restrição de Cw na posição inicial) = 0,2169; = 0,0654; = 1,4159; e Cw livre (sem restrição de Cw na posição inicial) = 0,0394; = 0,0077; = -2,0503. O melhor ajuste dos coeficientes de LIE foram obtidos nas simulações sem restrição da posição inicial de uma molécula de água conservada (Cw), essa escolha foi baseada no valor de energia livre absoluta da proteína c-ABL selvagem ( ) ser sempre um número mais negativo quando comparado com o valor da energia livre absoluta de cada proteína c-ABL mutada. O uso do método LIE (Linear Interaction Energy) com essa estratégia foi eficiente para analisar o efeito da interação entre diferentes proteínas c-ABL mutantes e um ligante (Imatinib ou Nilotinib). Até o momento não existem simulações de dinâmica molecular na presença de outros domínios da proteína BCR-ABL: SH2 e SH3.
84

Interação de citocromo 2E1 induzido por etanol e estresse oxidativo / Ethanol-induced 2E1 cytochrome interaction and oxidative stress

Ligia Ajaime Azzalis 02 October 2001 (has links)
Muitos autores associam as doenças alcoólicas hepáticas às deficiências nutricionais. Por outro lado, trabalhos experimentais estabelecem que a hepatotoxidade alcoólica relaciona-se especialmente à geração de espécies reativas através do sistema microsomal que oxida etanol via citocromo 450, principalmente o CYP2E1. O CYP2E1 hepático tem a capacidade de ativar algumas drogas comumente utilizadas, como o acetaminofeno, em seus metabólitos mais tóxicos e promover carcinogênese. Além. disso, o metabolismo pelo CYP2E1 resulta num aumento na produção de espécies reativas, com diminuição nos sistemas de defesa antioxidantes, estabelecendo o estresse oxidativo. Como a expressão do CYP2E1 é muito influenciada por fatores nutricionais e hormonais, este trabalho descreve os efeitos do tratamento com etanol nos níveis de CYP2E1 e sua relação com alguns parâmetros pró- e antioxidantes, considerando três modelos experimentais diferentes. Ratos machos Sprague Dawley com cerca de três meses de idade receberam ad lib. ração Purina (Purina Ind., Brasil) e, separadamente, uma solução 25 % etanol-20%sacarose durante 1, 2, 3 ou 4 semanas. Os grupos controles foram isocaloricamente pareados aos animais que consumiram etanol, ou receberam quantidades de sacarose equivalentes às calorias recebidas com o consumo de etanol. 18 h antes do sacrifício os animais foram mantidos em abstinência alcoólica, recebendo água e ração ou apenas água ad lib. Os resultados indicam que o consumo de etanol pode ser associado à estabilização do CYP2E1. No entanto, nas nossas condições experimentais, a presença da isoforma não está associada ao estresse oxidativo. Esses resultados indicam que as deficiências nutricionais, especialmente o baixo consumo de carboidratos, são fundamentais na potenciação do estresse oxidativo induzido pelo etanol. / Many authors have attributed alcoholic liver disease to dietary deficiencies. On the other hand, experimental studies have established that alcohol hepatotoxicity is especially related to the generation of oxidant species through its microsomal metabolism via cytochrome P-450, mainly CYP2E1. Liver CYP2E1 has a high capacity to activate some commonly used drugs, such as acetaminophen, to their toxic metabolites, and to promote carcinogenesis. Moreover, metabolism by CYP2E1 results in a significant reactive oxygen species (ROS) release, accompanied by the defense systems decrease against oxidative stress. Since the expression of CYP2E1 is very much influenced by hormonal and nutritional factors, this study describes the effects of ethanol treatment on CYP2E 1 levels and their relationship with some pro and antioxidant parameters considering three experimental models. Male Sprague-Dawley rats were fed ad. lib. for 1, 2, 3 or 4 weeks a commercial diet (Purina Ind., Brazil) plus a 25% ethanol-20% sucrose solution. Control groups were isocalorically pair-feed to the leading ethanol-consuming animals, or received isocaloric amounts of sucrose for pairing only ethanol calories. Eighteen hours before sacrifice ethanol was withdrawal and animals had only free access to tap water or they were offered food and water ad. lib. Results have shown that ethanol administration was associated with CYP2E1 stabilization although under our experimental condition it was not associated with any oxidative stress. These findings indicate that dietary deficiencies, especially low carbohydrate intake are crucial in the potentiation of the ethanol-induced oxidative stress.
85

Pre-clinical investigation of carnosine’s anti-neoplastic effect on glioblastoma: uptake, signal transduction, gene expression and tumour cell metabolism

Oppermann, Henry 18 September 2020 (has links)
Das Glioblastom ist der häufigste maligne Tumor des zentralen Nervensystems. Trotz leitliniengerechter Therapie, bestehend aus mikrochirurgischer Resektion, Strahlentherapie und ergänzender Chemotherapie mit Temozolomid, beträgt die 2-Jahres-Überlebensrate nur ca. 17%. Daher sind dringend neue Therapieansätze erforderlich. Dem natürlich vorkommenden Dipeptid Carnosin, welches vor über 100 Jahren erstmals isoliert wurde, konnten viele physiologische Funktionen zugeschrieben werden. Zu Beginn unserer Arbeiten war bekannt, dass das Dipeptid das Wachstum von Krebszellen inhibiert, wobei die genauen Mechanismen der antineoplastischen Wirkungsweise weitgehend unbekannt waren. Die Untersuchungen im Rahmen der vorliegenden Habilitationsarbeit setzten sich mit möglichen Wirkmechanismen des Dipeptides auseinander, wobei ebenfalls Fragestellungen zur klinischen Anwendung von Carnosin bearbeitet wurden. Im ersten Abschnitt werden die Transportmechanismen von Carnosin in Glioblastom-Zellen beschrieben. Weiterhin wird die Frage beantwortet, ob das Dipeptid die biologisch aktive Verbindung ist oder ob L-Histidin von Carnosin abgespalten werden muss, um die antineoplastische Wirkung zu entfalten. Der zweite Abschnitt beschäftigt sich mit den Einflüssen von Carnosin auf die Signaltransduktion und Genexpression. Im dritten Abschnitt wird unter anderem mit einem Metabolomics-Ansatz der Stoffwechsel von Glioblastom-Zellen charakterisiert und der Einfluss von Carnosin auf diesen bestimmt. Im vierten Abschnitt wird ein neuartiges Ko-Kultur Modell zur Untersuchung von Carnosins Einfluss auf Glioblastom-Zell-Migration und Koloniebildung vorgestellt. Weiterhin untersuchten wir die möglichen Interaktionen des Dipeptides mit der Standardtherapie von Glioblastomen. Zusammenfassend zeigten wir, dass Carnosin durch drei verschiedene Transporter aufgenommen werden kann. Das Dipeptid hemmt sowohl Proliferation und Migration von Glioblastom-Zellen. Die Spaltung des Dipeptides ist für seine antineoplastische Wirkung nicht notwendig. In die Zelle aufgenommen, wirkt Carnosin inhibitorisch auf den Pentosephosphatweg. Eine mögliche Erklärung dafür lieferte die beobachte nicht-enzymatische Reaktion von Glycerinaldehyd-3-phosphat mit dem Dipeptid. Weiterhin zeigten unsere Experimente zum ersten Mal eine Carnosin-bedingte Veränderung der Histonacetylierung und eine damit einhergehende Beeinflussung der Genexpression. Da das Dipeptid den Effekt der Radio-/Chemotherapie verstärkt, sollte die Wirkung von Carnosin in einer klinischen Studie an Glioblastom-Patienten untersucht werden. / Glioblastoma is the most common malignant tumour of the central nervous system. Only ~17% of patients undergoing standard therapy, including microsurgical resection, radiotherapy and adjuvant chemotherapy using temozolomide survive two years after diagnosis. Hence, new therapeutic approaches are urgently needed. The naturally occurring dipeptide carnosine was discovered more than 100 years ago. Since then, many physiological functions and beneficial effects have been ascribed to it. Previous studies demonstrated that carnosine inhibits growth of cancer cells. However, at the beginning of our investigations were the mechanisms behind carnosine’s anti-neoplastic effect mostly unknown. The present work addresses possible modes of action of carnosine and issues regarding the clinical application of the dipeptide. In the first paragraph we describe the transport mechanisms of carnosine in glioblastoma cells. Furthermore, we deal with the problem whether carnosine is the biological active compound or release of L-histidine from the dipeptide is required to deploy its anti-neoplastic effect. The second paragraph addresses the influence of carnosine on glioblastoma cell signal transduction and gene expression. In the third paragraph we characterise the metabolism of glioblastoma cells and how it is influenced by carnosine by using a metabolomics approach. The fourth paragraph introduces a novel co-culture model which allows the analysis of carnosine’s impact on glioblastoma cell migration and colony formation. Furthermore, the possible interaction of the dipeptide with the glioblastoma standard therapy is investigated. In conclusion, we demonstrated that three different transporters are capable for the uptake of carnosine in glioblastoma cells. The dipeptide inhibited in addition to proliferation also migration of glioblastoma cells. Moreover, cleavage of carnosine was not required for its anti-neoplastic effect. After taken up by the cell, carnosine inhibits the pentose phosphate pathway. The observed non-enzymatic reaction of glyceraldehyde-3-phosphate with the dipeptide could possibly explain this effect. Furthermore, our experiments showed for the first time that carnosine influences gene expression by an effect on histone acetylation. As the administration of carnosine arguments the effects of radio-/chemotherapy, we encourage the clinical evaluation of the dipeptide for glioblastoma patients.
86

Modeling Functional Modules Using Statistical and Machine Learning Methods

Cubuk, Cankut 30 November 2020 (has links)
[ES] La comprensión de los aspectos de la funcionalidad de las células que cuentan para los mecanismos de las enfermedades es el mayor reto de la medicina personalizada. A pesar de la disponibilidad creciente de los datos de genómica y transcriptómica, sigue existiendo una notable brecha entre la detección de las perturbaciones en la expresión de genes y la comprensión de su contribución en los mecanismos moleculares que últimamente tienen relación importante con el fenotipo estudiado. A lo largo de la última década, distintos modelos computacionales y matemáticos se han propuesto para el análisis de las rutas. Sin embargo, estos modelos no toman en cuenta los mecanismos dinámicos de las rutas como la estructura y las interacciones entre genes y proteínas. En esta tesis doctoral, presento dos modelos matemáticos ligeramente distintos, para integrar los datos transcriptómicos masivos de humano con un conocimiento previo de de las rutas de señalización y metabólicas para estimar las actividades mecánicas que están detrás de esas rutas (MPAs). Las MPAs son variables continuas con valores de nivel individual que pueden ser usadas con los modelos de aprendizaje de máquinas y métodos estadísticos para determinar los biomarcadores que podemos usar para los diagnósticos tempranos y la clasificación de subtipos de enfermedades, además de poder sugerir las dianas terapéuticas potenciales para las intervenciones individualizadas. El objetivo global es desarrollar nuevos y avanzados enfoques de la biología de sistemas para proponer unas hipótesis funcionales que nos ayuden a entender e interpretar los mecanismos complejos de las enfermedades. Estos mecanismos son cruciales para mejorar los tratamientos personalizados y predecir los resultados clínicos. En primer lugar, contribuí al desarrollo de un método que está diseñado para extraer las subrutas elementales desde la ruta de señalización con sus actividades estimadas. Posteriormente, este algoritmo se ha adaptado a los módulos metabólicos y se ha implementado como una herramienta web. Finalmente , el método ha revelado un panorama metabólico para una lista completa de diferentes tipos de cánceres. En este estudio, analicé el perfil metabólico de 25 tipos de cáncer distintos y se validó el método usando varios enfoques computacionales y experimentales. Cada método desarrollado en esta tesis ha sido enfrentado a otros métodos similares existentes, evaluados por sus sensibilidades y especificidades, experimentalmente validados cuando fue posible y usados para predecir resultados clínicos de varios tipos de cánceres. La investigación descrita en esta tesis y los resultados obtenidos fueron publicados en distintas revistas arbitradas que están relacionadas con el cáncer y biología de sistemas, y también en los periódicos nacionales. / [CA] La comprensió dels aspectes de la funcionalitat de les cèl·lules que compten per als mecanismes de les malalties és el major repte de la medicina personalitzada. Malgrat la disponibilitat creixent de les dades de genòmica i transcriptómica, continua existint una notable bretxa entre la detecció de les pertorbacions en l'expressió de gens i la comprensió de la seua contribució en els mecanismes moleculars que últimament tenen relació important amb el fenotip estudiat. Al llarg de l'última dècada, diferents models computacionals i matemàtics s'han proposat per a l'anàlisi de les rutes. No obstant això, aquests models no tenen en compte els mecanismes dinàmics de les rutes com l'estructura i les interaccions entre gens i proteïnes. En aquesta tesi doctoral, presente dos models matemàtics lleugerament diferents, per a integrar les dades transcriptómicos massius d'humà amb un coneixement previ de de les rutes de senyalització i metabòliques per a estimar les activitats mecàniques que estan darrere d'aqueixes rutes (MPAs). Les MPAs són variables contínues amb valors de nivell individual que poden ser usades amb els models d'aprenentatge de màquines i mètodes estadístics per a determinar els biomarcadores que podem usar per als diagnòstics primerencs i la classificació de subtipus de malalties, a més de poder suggerir les dianes terapèutiques potencials per a les intervencions individualitzades. L'objectiu global és desenvolupar nous i avançats enfocaments de la biologia de sistemes per a proposar unes hipòtesis funcionals que ens ajuden a entendre i interpretar els mecanismes complexos de les malalties. Aquests mecanismes són crucials per a millorar els tractaments personalitzats i predir els resultats clínics. En primer lloc, vaig contribuir al desenvolupament d'un mètode que està dissenyat per a extraure les subrutas elementals des de la ruta de senyalització amb les seues activitats estimades. Posteriorment, aquest algorisme s'ha adaptat als mòduls metabòlics i s'ha implementat com una eina web. Finalment, el mètode ha revelat un panorama metabòlic per a una llista completa de diferents tipus de càncers. En aquest estudi, vaig analitzar el perfil metabòlic de 25 tipus de càncer diferents i es va validar el mètode usant diversos enfocaments computacionals i experimentals. Cada mètode desenvolupat en aquesta tesi ha sigut enfrontat a altres mètodes similars existents, avaluats per les seues sensibilitats i especificitats, experimentalment validats quan va ser possible i usats per a predir resultats clínics de diversos tipus de càncers. La investigació descrita en aquesta tesi i els resultats obtinguts van ser publicats en diferents revistes arbitrades que estan relacionades amb el càncer i biologia de sistemes, i també en els periòdics nacionals. / [EN] Understanding the aspects of the cell functionality that account for disease or drug action mechanisms is the main challenge for precision medicine. In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Over the last decade, different computational and mathematical models have been proposed for pathway analysis. However, they are not taking into account the dynamic mechanisms contained by pathways as represented in their layout and the interactions between genes and proteins. In this thesis, I present two slightly different mathematical models to integrate human transcriptomic data with prior knowledge of signalling and metabolic pathways to estimate the Mechanistic Pathway Activities (MPAs). MPAs are continuous and individual level values that can be used with machine learning and statistical methods to determine biomarkers for the early diagnosis and subtype classification of the diseases, and also to suggest potential therapeutic targets for individualized therapeutic interventions. The overall objective is, developing new and advanced systems biology approaches to propose functional hypotheses that help us to understand and interpret the complex mechanism of the diseases. These mechanisms are crucial for robust personalized drug treatments and predict clinical outcomes. First, I contributed to the development of a method which is designed to extract elementary sub-pathways from a signalling pathway and to estimate their activity. Second, this algorithm adapted to metabolic modules and it is implemented as a webtool. Third, the method used to reveal a pan-cancer metabolic landscape. In this study, I analyzed the metabolic module profile of 25 different cancer types and the method is also validated using different computational and experimental approaches. Each method developed in this thesis was benchmarked against the existing similar methods, evaluated for their sensitivity and specificity, experimentally validated when it is possible and used to predict clinical outcomes of different cancer types. The research described in this thesis and the results obtained were published in different systems biology and cancer-related peer-reviewed journals and also in national newspapers. / Cubuk, C. (2020). Modeling Functional Modules Using Statistical and Machine Learning Methods [Tesis doctoral]. Universitat Politècnica de València. https://doi.org/10.4995/Thesis/10251/156175 / TESIS
87

Genome Evolution and Specialized Metabolic Gene Innovation in the Medicinal Plant Lithospermum erythrorhizon and the Toxic Alga Prymnesium parvum

Robert P. Auber (12469860) 27 April 2022 (has links)
<p>Specialized metabolites are chemical tools produced by organisms to aid in their interaction with the surrounding environment. These diverse compounds can often function as metabolic weapons (<em>e.g.</em> antibiotics), structural components (<em>e.g.</em> lignins), or even attractants (<em>e.g.</em> flavonoids). Because of their frequent utilization in niche environments, specialized metabolite production is often lineage- or even species-specific. Therefore, knowledge between specialized metabolic systems is often nontransferable, which poses a major obstacle in the characterization of these bioactive and commercially relevant compounds. Beyond resolving the chemical composition of a specialized metabolite, the identification of responsible pathway genes and the evolutionary processes responsible for their formation is an arduous task. These gaps in knowledge are further widened by the lack of genomic resources available for specialized metabolite producing species. In this work, we present the genome assemblies of two organisms, each with unique specialized metabolic pathways: the Chinese medicinal plant <em>Lithospermum erythrorhizon </em>and the toxic golden alga <em>Prymnesium parvum. </em>Leveraging the predicted proteome of <em>L. erythrorhizon</em>, we investigated the evolutionary history of specialized metabolic genes responsible for the production of shikonin, a 1,4-naphthoquinone specialized metabolite. We identified a retrotransposition-mediated duplication event responsible for the creation of the core shikonin biosynthesis gene, <em>PGT</em>. In addition, we performed a global coexpression network analysis to identify regulatory and enzymatic gene candidates involved in the shikonin biosynthesis pathway. We also built phylogenetic trees of known and candidate shikonin genes to reveal patterns of lineage-specific gene duplication and retroduplication. Like plants, unicellular algae are known for their production of diverse, often toxic, specialized metabolites. However, these species are often enigmatic. For example, previous studies have documented large phenotypic variation in both toxin chemotypes and levels among different strains of <em>P. parvum</em>. To investigate the genetic basis of this variation, we generated near chromosome level assemblies of two <em>P. parvum </em>strains and performed a broad genome survey of thirteen additional strains. As a result, we identified a commonly studied reference strain, UTEX 2797, as a hybrid with two distinct subgenomes. We also provide evidence of significant variation in haploid genome size across the species. Collectively, these studies supply genetic resources for the future study of these organisms, as well as provide insight into the evolution of their specialized metabolic pathways.</p>
88

The von Hippel-Lindau protein and collagen IV alpha 2 : an insight into the mechanisms by which the von Hippel-Lindau protein regulates extracellular matrix assembly and function

Ramlal, Nishant. January 2008 (has links)
No description available.
89

NOTCH SIGNALING REGULATES STEMNESS AND METABOLISM OF LIPOSARCOMA CELLS

Pei Chieh Tien (14232620) 09 December 2022 (has links)
<p>Liposarcoma (LPS) arises from adipocytes and is a rare malignancy among all cancer types, but represents the most common form of soft tissue sarcoma, with approximately 2,000 new cases reported annually. Clinically, liposarcomas are classified into four subtypes based on histological analysis: well-differentiated liposarcoma (WDLPS), dedifferentiated liposarcoma (DDLPS), myxoid/round cell liposarcoma, and pleomorphic liposarcoma. Although histological analysis provides useful information for identifying various liposarcoma subtypes, treatment options rely on a fundamental understanding of driver mutations and molecular mechanisms underlying tumorigenesis. This thesis focuses on elucidating important driver mutations and therapeutic targets to eradicate DDLPS. Notch signaling is an evolutionarily conserved signaling pathway essential for organ development and stem cell function. Aberrant Notch signaling underlies the tumorigenesis of many cancers including LPS. However, the specific role of Notch signaling in development of LPS remains elusive. In Chapter 2, I provide evidence demonstrating that Notch signaling plays a key role in cancer stem cells (CSCs), also referred to as tumor-initiating cells (TICs), that drive aggressive DDLPS. I used serial transplantation to enrich and generate a murine DDLPS cell line with constitutively activated Notch signaling (NICDOE). My analyses revealed that NICDOE DDLPS cells are heterogeneous and contain TICs that express cancer stem cell markers. Chapter 3 elucidates how Notch signaling regulates CSCs of LPS. I analyzed human LPS samples to establish a strong correlation between Notch signaling activation and tumor marker expression and prognosis. I further performed gene expression and metabolic analyses of NICDOE DDLPS cells. These assays revealed that NICDOE reduced mitochondrial respiration in DDLPS cells, which was associated with diminished expression of peroxisome proliferator-activated receptor gamma coactivator 1α (PGC-1α), a master regulator of mitochondrial biogenesis. CRISPR/CAS9-mediated deletion of the NICDOE cassette rescued the expression of PGC-1α and mitochondrial respiration in DDLPS cells. Similarly, overexpression of PGC-1α was sufficient to rescue mitochondrial biogenesis in DDLPS cells. Together, these data demonstrate that Notch signaling regulates CSCs, at least partially by controlling PGC-1α mediated mitochondria biogenesis.</p>
90

Critical Investigation of the Usability of Hepatoma Cell Lines HepG2 and Huh7 as Models for the Metabolic Representation of Resectable Hepatocellular Carcinoma

Schicht, Gerda, Seidemann, Lena, Haensel, Rene, Seehofer, Daniel, Damm, Georg 05 December 2023 (has links)
Metabolic alterations in hepatocellular carcinoma (HCC) are fundamental for the development of diagnostic screening and therapeutic intervention since energy metabolism plays a central role in differentiated hepatocytes. In HCC research, hepatoma cell lines (HCLs) like HepG2 and Huh7 cells are still the gold standard. In this study, we characterized the metabolic profiles of primary human hepatoma cells (PHCs), HCLs and primary human hepatocytes (PHHs) to determine their differentiation states. PHCs and PHHs (HCC-PHHs) were isolated from surgical specimens of HCC patients and their energy metabolism was compared to PHHs from non-HCC patients and the HepG2 and Huh7 cells at different levels (transcript, protein, function). Our analyses showed successful isolation of PHCs with a purity of 50–73% (CK18+). The transcript data revealed that changes in mRNA expression levels had already occurred in HCC-PHHs. While many genes were overexpressed in PHCs and HCC-PHHs, the changes were mostly not translated to the protein level. Downregulated metabolic key players of PHCs revealed a correlation with malign transformation and were predominantly pronounced in multilocular HCC. Therefore, HCLs failed to reflect these expression patterns of PHCs at the transcript and protein levels. The metabolic characteristics of PHCs are closer to those of HCC-PHHs than to HCLs. This should be taken into account for future optimized tumor metabolism research.

Page generated in 0.1365 seconds